VoxCell Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Investors
  • 25

VoxCell General Information

Description

Developer of three dimensional bioprinted human tissue models designed to enhance drug development and testing accuracy. The company offers vascularized, physiologically relevant tissue constructs that replicate human biology, enabling pharmaceutical researchers and drug developers to predict clinical outcomes and accelerate therapeutic discovery.

Contact Information

Website
www.voxcell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 637 Bay Street
  • Suite 300
  • Victoria, British Columbia V8T 5L2
  • Canada
+1 (672)
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
3D Printing, Life Sciences, Oncology
Corporate Office
  • 637 Bay Street
  • Suite 300
  • Victoria, British Columbia V8T 5L2
  • Canada
+1 (672)

VoxCell Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VoxCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Later Stage VC (Series A) Upcoming Generating Revenue
19. Later Stage VC 01-Sep-2026 Completed Generating Revenue
18. Early Stage VC Cancelled Generating Revenue
17. Accelerator/Incubator Completed Generating Revenue
16. Accelerator/Incubator Completed Generating Revenue
15. Seed Round 21-Mar-2025 Completed Generating Revenue
14. Seed Round 01-Jan-2024 Completed Generating Revenue
13. Accelerator/Incubator Completed Generating Revenue
12. Accelerator/Incubator 14-Jun-2023 $1.63M Completed Generating Revenue
11. Seed Round 01-Jan-2023 $1.54M $1.63M Completed Generating Revenue
To view VoxCell’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

VoxCell Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

VoxCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025236086-A1 Temperature regulator apparatus, kits, methods, and systems Pending 10-May-2024
WO-2025166443-A1 3d bioprinter apparatus, kits, method, and systems for 3d printing tissue models with bioinks containing living cells Pending 09-Feb-2024
US-20260207790-A1 Bioinks and methods of synthesizing, characterizing, and deploying bioinks Pending 15-Dec-2022
WO-2024124356-A1 Bioinks and methods of synthesizing, characterizing, and deploying bioinks Inactive 15-Dec-2022
EP-4479456-A1 Ph responsive gelma polymers and related methods of synthesizing, fabricating, and deploying ph responsive polymers Pending 15-Feb-2022 A61K9/1658
To view VoxCell’s complete patent history, request access »

VoxCell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VoxCell Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Providence Health Care Ventures Corporate Venture Capital Minority
CABHI Corporate Venture Capital Minority
Creative Destruction Lab Accelerator/Incubator
Adara Venture Capital Venture Capital Minority
Archangel Network of Funds Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

Ready to get started?

Request a free trial

VoxCell FAQs

  • When was VoxCell founded?

    VoxCell was founded in 2020.

  • Where is VoxCell headquartered?

    VoxCell is headquartered in Victoria, Canada.

  • What is the size of VoxCell?

    VoxCell has 30 total employees.

  • What industry is VoxCell in?

    VoxCell’s primary industry is Drug Discovery.

  • Is VoxCell a private or public company?

    VoxCell is a Private company.

  • What is VoxCell’s current revenue?

    The current revenue for VoxCell is .

  • How much funding has VoxCell raised over time?

    VoxCell has raised $14.2M.

  • Who are VoxCell’s investors?

    Providence Health Care Ventures, CABHI, Creative Destruction Lab, Adara Venture Capital, and Archangel Network of Funds are 5 of 25 investors who have invested in VoxCell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process